Ian Andrew Wilson

Title: The Innovative Contributions of Ian Andrew Wilson

Introduction

Ian Andrew Wilson is a notable inventor based in Amersham, GB. He has made significant contributions to the field of medical technology, particularly in cancer treatment. With a total of six patents to his name, Wilson's work focuses on improving therapy selection and monitoring for cancer patients.

Latest Patents

Among his latest patents is an innovative anti-met therapy designed for previously diagnosed cancer patients. This invention relates to methods that assist in selecting suitable cancer patients for therapies directed at c-Met. The method utilizes imaging agents that comprise F-radiolabelled c-Met binding peptides, which are suitable for positron emission tomography (PET) imaging in vivo. Another significant patent is a therapy selection method aimed at patients suffering from Barrett's oesophagus, particularly when first-line therapy has failed and dysplasia has been diagnosed. This method employs an imaging agent that targets Her2, c-Met, guanylyl cyclase, or IGF1R, and is suitable for radioisotope or optical imaging in vitro or preferably in vivo.

Career Highlights

Ian Andrew Wilson has worked with prominent companies in the healthcare sector, including GE Healthcare Limited and GE Healthcare AS. His experience in these organizations has contributed to his expertise in developing innovative medical technologies.

Collaborations

Throughout his career, Wilson has collaborated with notable individuals such as Anthony Eamon Storey and Marivi Mendizabal. These collaborations have likely enriched his work and led to advancements in his inventions.

Conclusion

Ian Andrew Wilson's contributions to medical technology, particularly in cancer treatment, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing therapeutic methods and enhancing the selection process for cancer treatments.